« Previous
Next »
Cancer Letters
Volume 224, Issue 1
, Pages
111-116
, 16 June 2005
The PPARγ K422Q mutation does not contribute to troglitazone inefficiency in colon cancer treatment
To access this article, please choose from the options below
PII: S0304-3835(04)00779-7
doi: 10.1016/j.canlet.2004.10.011
© 2004 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Cancer Letters
Volume 224, Issue 1
, Pages
111-116
, 16 June 2005
